VIENNA—Semperit A.G. Holding has confirmed its 2021 earnings outlook at $482 million and with a strong liquidity position is "well-positioned" for potential merger and acquisition transactions, the Austrian polymer group announced May 19.
Semperit said demand began to increase for its industrial products at the end of 2020, following a year of global recession.
The Vienna-based group said it expected a noticeable recovery for its industrial segment—comprised of four segments Semperflex, Sempertrans, Semperseal and Semperform—in 2021.
Semperit also reaffirmed its strategic decision to focus on the industrial sector but did not provide any updates on the planned divestment of its medical gloves unit Sempermed.
The ongoing effects of the COVID-19 pandemic continue to have a positive impact on the price of medical products and the performance of its Sempermed business unit, the group said.
The group believes the peak of the price development was reached at the end of the first quarter and the price level will slowly decrease over the course of the year.
Despite broad-scale vaccination programs, Semperit said it believed that "a clearly positive price deviation compared to the pre-corona level will continue until well into 2021."
